Last 2,320 KRW
Change Today -30.00 / -1.28%
Volume 211.5K
004310 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:28 AM 04/18/14 All times are local (Market data is delayed by at least 15 minutes).

hyundai pharmaceutical co lt (004310) Snapshot

Open
2,345
Previous Close
2,350
Day High
2,345
Day Low
2,270
52 Week High
03/26/14 - 2,415
52 Week Low
06/25/13 - 1,545
Market Cap
65.0B
Average Volume 10 Days
314.5K
EPS TTM
-207.00
Shares Outstanding
28.0M
EX-Date
11/28/13
P/E TM
--
Dividend
42.50
Dividend Yield
1.83%
Current Stock Chart for HYUNDAI PHARMACEUTICAL CO LT (004310)

Related News

No related news articles were found.

hyundai pharmaceutical co lt (004310) Related Businessweek News

No Related Businessweek News Found

hyundai pharmaceutical co lt (004310) Details

Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products and health drinks in South Korea. Its principal products include Tenormin, which is used for hypertension treatment; Miero Fiber and Miero BeautyN health drinks; Tachocomb hemostatic medicine; Norlevo Tablet postcoital contraception peel; Derma White Tablet and Derma Clearance skin whitening products; Disweat Syrup hyperhidrosis treatment; and Parokin Tablet for Parkinson’s disease. The company also provides treatment medicines for diabetes mellitus, Alzheimer’s disease, schizophrenia, respiratory organ, alopecia, and insect bites. It sells its products through wholesale stores, hospitals, and agencies. The company was founded in 1965 and is headquartered in Seoul, South Korea.

Founded in 1965

hyundai pharmaceutical co lt (004310) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hyundai pharmaceutical co lt (004310) Key Developments

Hyundai Pharmaceutical Co., Ltd., Annual General Meeting, Feb 13, 2014

Hyundai Pharmaceutical Co., Ltd., Annual General Meeting, Feb 13, 2014., at 10:00 Korea Standard Time. Location: dong, Nam-gu, Cheonan Hyundai 55 pungsemyeon street drugs. Agenda: To consider approval of financial statements; to consider incorporation of some changes; to consider election of directors; and to consider approval of directors' remuneration limit.

Hyundai Pharmaceutical Co., Ltd., Annual General Meeting, Feb 14, 2013

Hyundai Pharmaceutical Co., Ltd., Annual General Meeting, Feb 14, 2013., at 10:00 Korea Standard Time. Location: Cheonan-dong, Nam-gu.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
004310:KS 2,320.00 KRW -30.00

004310 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 004310.
View Industry Companies
 

Industry Analysis

004310

Industry Average

Valuation 004310 Industry Range
Price/Earnings 39.4x
Price/Sales 0.5x
Price/Book 0.6x
Price/Cash Flow 36.0x
TEV/Sales 0.3x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HYUNDAI PHARMACEUTICAL CO LT, please visit www.hyundaipharm.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.